My general framework: Start with semaglutide if cost is a significant concern, or if there is no strong reason to expect poor tolerance Start with tirzepatide if the patient has tried semaglutide before and struggled with side effects, if faster initial response matters clinically, or if the patients goals require larger total weight loss Switch to tirzepatide if a patient on semaglutide is experiencing persistent nausea or has plateaued and escalation options are limited One pattern worth noting: men I see a consistent pattern with male patients who struggle to tolerate semaglutide nausea and GI disruption can be particularly disruptive for them, and theyre often less willing to push through it
GLP-1 Multidistrict Litigation Status 2025 As of 2025, hundreds of Ozempic lawsuits filed against Novo Nordisk have been consolidated into multidistrict litigation (MDL) in the Eastern District of Pennsylvania
Anti-Inflammatory Protocols: Often included in rehab or post-surgery peptide stacks
The form asks whether Wegovy will be used with other GLP-1 analogs and whether the dose will exceed 2.4 mg once weekly
Its approval has already improved the lives of chronically overweight patients
transitory exanthema Miscellaneous: Feeling of swelling of entire body Cyanocobalamin Dosage and Administration Avoid using the intravenous route